Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze APVO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate APVO investment potential.

What is APVO stock price today?

Get real-time APVO stock price, historical data, and price charts on Financhill. Track APVO performance with our advanced analysis tools.

Is APVO a good investment?

Evaluate APVO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy APVO stock?

To buy APVO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of APVO?

View detailed market capitalization data and company valuation metrics for APVO on our comprehensive analysis page.

What is the P/E ratio of APVO?

Use our fundamental analysis tools to view APVO P/E ratio and compare valuation metrics with industry peers.

What are APVO earnings?

View APVO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Aptevo Therapeutics, Inc. Stock Predictions

Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.

Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets

Sell

APVO
Aptevo Therapeutics, Inc.

Last Price:

$8.92

Seasonality Move:

-18.8%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Aptevo Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Aptevo Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 9 years of stock performance.
Aptevo Therapeutics, Inc. has fallen lower in 9 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Is Aptevo Therapeutics, Inc. Stock Undervalued?

The current Aptevo Therapeutics, Inc. [APVO] share price is $9.29. The Score for APVO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Aptevo Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Aptevo Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 9 years of stock performance.

Aptevo Therapeutics, Inc. Stock Rating

Sell

Aptevo Therapeutics, Inc. (APVO) is a Sell

Is Aptevo Therapeutics, Inc. overpriced?

Aptevo Therapeutics, Inc. has fallen lower in 9 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Aptevo Therapeutics, Inc. Stock Price History

Is APVO stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

aptevotherapeutics.com

52-Week Data

52-Week High:

1,807.19

52-Week Low:

7.66

Prediction Charts

Market Cap:

151.5M

Price in USD:

9.29

Volume:

95.1K

Beta:

4.46

Technical Analysis

SMA50:

18.30

SMA100:

23.21

SMA200:

73.25

52-Wk Change:

-99.43%

Stock Predictions

Is Aptevo Therapeutics, Inc. stock public?

Yes, Aptevo Therapeutics, Inc. is a publicly traded company.
What is the Aptevo Therapeutics, Inc. stock quote today?

The Aptevo Therapeutics, Inc. stock price is 9.29 USD today.
How to buy Aptevo Therapeutics, Inc. stock online?

You can buy Aptevo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-30	9.90	9.39	10.17	9.13
Dec-31	9.29	9.43	10.66	9.28
Jan-5	9.27	8.32	9.30	8.02
Jan-6	8.42	7.95	8.46	7.91
Jan-7	7.95	8.91	9.14	7.66
Jan-8	8.68	9.20	9.37	8.62
Jan-9	9.81	9.66	9.90	8.10
Jan-12	8.65	8.97	9.11	8.65
Jan-13	8.83	8.88	9.05	8.49
Jan-14	8.67	9.01	9.09	8.50
Jan-15	8.92	9.03	9.10	8.55
Jan-16	9.01	9.45	9.60	8.82
Jan-20	9.26	9.83	10.70	9.02
Jan-21	9.74	9.29	9.97	8.90

Aptevo Therapeutics, Inc. Earnings

Aptevo Therapeutics, Inc. Earnings Report: Per Share Aptevo Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aptevo Therapeutics, Inc. Forecast Revenue Growth

Aptevo Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aptevo Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $68.04 per share, and an increase next year of $0.90 per share.

* Aptevo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.